A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman

Coronavirus disease 2019 (COVID‐19) vaccination is reportedly safe and effective. The histologic features of post‐COVID‐19 vaccination myocarditis are unknown. We present a case of a 77‐year‐old Japanese woman diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after the seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Kaishi, Matsuo, Takashi, Ishimatsu, Takashi, Fukae, Atsuki, Hamamoto, Takuro, Oku, Koji, Ito, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445258/
https://www.ncbi.nlm.nih.gov/pubmed/36093466
http://dx.doi.org/10.1002/ccr3.6161
Descripción
Sumario:Coronavirus disease 2019 (COVID‐19) vaccination is reportedly safe and effective. The histologic features of post‐COVID‐19 vaccination myocarditis are unknown. We present a case of a 77‐year‐old Japanese woman diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after the second dose of BNT162b2 COVID‐19 vaccine. Steroid pulse therapy was effective.

Ejemplares similares